Duration and intensity of NF-κB activity determine the severity of endotoxin-induced acute lung injury

Journal of Immunology

Volumn 176, Issue 8, 2006, Pages 4995-5005

  Everhart, M Brett ^a   Han, Wei ^a   Sherrill, Taylor P ^a   Arutiunov, Melissa ^a   Polosukhin, Vasiliy V ^a   Burke, James R ^d   Sadikot, Ruxana T ^a,b   Christman, John W ^c   Yull, Fiona E ^a   Blackwell, Timothy S ^a,b,e  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BMS 345541; ENDOTOXIN; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 2; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL TYPE; CONTROLLED STUDY; DISEASE DURATION; DOWN REGULATION; ESCHERICHIA COLI; IMMUNOSTIMULATION; IMPLANTATION; INJURY SEVERITY; LUNG ALVEOLUS CELL; LUNG EDEMA; LUNG LAVAGE; MOUSE; NEUTROPHIL; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; TISSUE INJURY; TRANSGENIC MOUSE;

EID: 33645769722     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.8.4995     Document Type: Article

References (39)

1. Blackwell, T. S., E. P. Holden, T. R. Blackwell, J. E. DeLarco, and J. W. Christman. 1994. Cytokine-induced neutrophil chemoattractant mediates neutrophilic alveolitis in rats: association with nuclear factor κB activation. Am. J. Respir. Cell Mol. Biol. 11: 464-472.
2. Haddad, E. B., M. Salmon, H. Koto, P. J. Bames, I. Adcock, and K. F. Chung. 1996. Ozone induction of cytokine-induced neutrophil chemoattractant (CINC) and nuclear factor-κb in rat lung: inhibition by corticosteroids. FEBS Lett. 379: 265-268.
3. Shenkar, R., M. D. Schwartz, L. S. Terada, J. E. Repine, J. McCord, and E. Abraham. 1996. Hemorrhage activates NF-κB in murine lung mononuclear cells in vivo. Am. J. Physiol. 270: L729-L735.
4. Sacks, M., I. Gordon, J. Bylander, D. Porter, X. L. Shi, V. Castranova, W. Kaczmarczyk, K. Van Dyke, and M. J. Reasor. 1998. Silica-induced pulmonary inflammation in rats: activation of NF-κB and its suppression by dexamethasone. Biochem. Biophys. Res. Commun. 253: 181-184.
5. Browder, W., T. Ha, L. Chuanfu, J. H. Kalbfleisch, D. A. Ferguson, Jr., and D. L. Williams. 1999. Early activation of pulmonary nuclear factor κB and nuclear factor interleukin-6 in polymicrobial sepsis. J. Trauma 46: 590-596.
6. Mizgerd, J. P., J. J. Peschon, and C. M. Doerschuk. 2000. Roles of tumor necrosis factor receptor signaling during murine Escherichia coli pneumonia. Am. J. Respir. Cell Mol. Biol. 22: 85-91.
7. Mizgerd, J. P., M. R. Spieker, and C. M. Doerschuk. 2001. Early response cytokines and innate immunity: essential roles for TNF receptor 1 and type I IL-1 receptor during Escherichia coli pneumonia in mice. J. Immunol. 166: 4042-4048.
8. Sadikot, R. T., E. D. Jansen, T. R. Blackwell, O. Zoia, F. Yull, J. W. Christman, and T. S. Blackwell. 2001. High-dose dexamethasone accentuates nuclear factor-κB activation in endotoxin-treated mice. Am. J. Respir. Crit. Care Med. 164: 873-878.
9. Blackwell, T. S., J. P. Debelak, A. Venkatakrishnan, D. J. Schot, D. H. Harley, C. W. Pinson, P. Williams, K. Washington, J. W. Christman, and W. C. Chapman. 1999. Acute lung injury after hepatic cryoablation: correlation with NF-κB activation and cytokine production. Surgery 126: 518-526.
10. Blackwell, T. S., F. E. Yull, C. L. Chen, A. Venkatakrishnan, T. R. Blackwell, D. J. Hicks, L. H. Lancaster, J. W. Christman, and L. D. Kerr. 2000. Multiorgan nuclear factor κB activation in a transgenic mouse model of systemic inflammation. Am. J. Respir. Crit. Care Med. 162: 1095-1101.
11. Lauzurica, P., S. Martínez-Martínez, M. Marazuela, P. Gómez del Arco, C. Martínez-A, F. Sánchez-Madrid, and J. M. Redondo. 1999. Pyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNF-α. Eur. J. Immunol. 29: 1890-1900.
12. Liu, S. F., X. Ye, and A. B. Malik. 1999. Pyrrolidine dithiocarbamate prevents I-κB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. Mol. Pharmacol. 55: 658-667.
13. Blackwell, T. S., T. R. Blackwell, E. P. Holden, B. W. Christman, and J. W. Christman. 1996. In vivo antioxidant treatment suppresses nuclear factor-κB activation and neutrophilic lung inflammation. J. Immunol. 157: 1630-1637.
14. Alcamo, E., J. P. Mizgerd, B. H. Horwitz, R. Bronson, A. A. Beg, M. Scott, C. M. Doerschuk, R. O. Hynes, and D. Baltimore. 2001. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-κB in leukocyte recruitment. J. Immunol. 167: 1592-1600.
15. Lawrence, T., D. W. Gilroy, P. R. Colville-Nash, and D. A. Willoughby. 2001. Possible new role for NF-κB in the resolution of inflammation. Nat. Med. 7: 1291-1297.
16. Abraham, E., A. Carmody, R. Shenkar, and J. Arcaroli. 2000. Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am. J. Physiol. 279: L1137-L1145.
17. phox deficiency impairs NF-κB activation and host defense in Pseudomonas pneumonia. J. Immunol. 172: 1801-1808.
18. Sadikot, R. T., W. Han, M. B. Everhart, O. Zoia, R. S. Peebles, E. D. Jansen, F. E. Yull, I. W. Christman, and T. S. Blackwell. 2003. Selective IκB kinase expression in airway epithelium generates neutrophilic lung inflammation. J. Immunol. 170: 1091-1098.
19. Burke, J. R., M. A. Pattoli, K. R. Gregor, P. J. Brassil, J. F. MacMaster, K. W. McIntyre, X. Yang, V. S. Iotzova, W. Clarke, J. Strnad, et al. 2003. BMS-345541 is a highly selective inhibitor of IκB kinase that binds at an allosteric site of the enzyme and blocks NF-κB-dependent transcription in mice. J. Biol. Chem. 278: 1450-1456.
20. Rojas, M., C. R. Woods, A. L. Mora, J. Xu, and K. L. Brigham. 2005. Endotoxin-induced lung injury in mice: structural, functional, and biochemical responses. Am. J. Physiol. 288: L333-L341.
21. Yull, F. E., W. Han, E. D. Jansen, M. B. Everhart, R. T. Sadikot, J. W. Christman, and T. S. Blackwell. 2003. Bioluminescent detection of endotoxin effects on HIV-1 LTR-driven transcription in vivo. J. Histochem. Cytochem. 51: 741-749.
22. McIntyre, K. W., D. J. Shuster, K. M. Gillooly, D. M. Dambach, M. A. Pattoli, P. Lu, X.-D. Zhou, Y. Qiu, F. C. Zusi, and J. R. Burke. 2003. A highly selective inhibitor of IκB kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice. Arthritis Rheum. 48: 2652-2659.
23. Gonçalves, A. S., and R. Appelberg. 2002. The involvement of the chemokine receptor CXCR2 in neutrophil recruitment in LPS-induced inflammation and in Mycobacterium avium infection. Scand. J. Immunol. 55: 585-591.
24. Muir, A., G. Soong, S. Sokol, B. Reddy, M. I. Gomez, A. Van Heeckeren, and A. Prince. 2004. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 30: 777-783.
25. Fan, J., R. S. Frey, and A. B. Malik. 2003. TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J. Clin. Invest. 112: 1234-1243.
26. MacMaster, J. F., D. M. Dambach, D. B. Lee, K. K. Berry, Y. Qiu, F. C. Zusi, and J. R. Burke. 2003. An inhibitor of IκB kinase, BMS-345541, blocks endothelial cell adhesion molecule expression and reduces the severity of dextran sulfate sodium-induced colitis in mice. Inflamm. Res. 52: 508-511.
27. Townsend, R. M., J. Postelnek, V. Susulic, K. W. McIntyre, D. J. Shuster, Y. Qiu, F. C. Zusi, and J. R. Burke. 2004. A highly selective inhibitor of IκB kinase, BMS-345541, augments graft survival mediated by suboptimal immunosuppression in a murine model of cardiac graft rejection. Transplantation 77: 1090-1094.
28. Matthay, M. A., and G. A. Zimmerman. 2005. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am. J. Respir. Cell Mol. Biol. 33: 319-327.
29. Kollef, M. H., and D. P. Schuster. 1995. The acute respiratory distress syndrome. N. Engl. J. Med. 332: 27-37.
30. Ware, L. B., and M. A. Matthay. 2000. The acute respiratory distress syndrome. N. Engl. J. Med. 342: 1334-1349.
31. Bhatia, M., and S. Moochhala. 2004. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J. Pathol 202: 145-156.
32. Goodman, R. B., R. M. Strieter, D. P. Martin, K. P. Steinberg, J. A. Milberg, R. J. Maunder, S. L. Kunkel, A. Walz, L. D. Hudson, and T. R. Martin. 1996. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154: 602-611.
33. Schütte, H., J. Lohmeyer, S. Rosseau, S. Ziegler, C. Siebert, H. Kielisch, H. Pralle, F. Grimminger, H. More, and W. Seeger. 1996. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur. Respir. J. 9: 1858-1867.
34. Miller, E. J., A. B. Cohen, S. Nagao, D. Griffith, R. J. Maunder, T. R. Martin, J. P. Weiner-Kronish, M. Sticherling, E. Christophers, and M. A. Matthay. 1992. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am. Rev. Respir. Dis. 146: 427-432.
35. Donnelly, S. C., R. M. Strieter, S. L. Kunkel, A. Walz, C. R. Robertson, D. C. Carter, J. S. Grant, A. J. Pollok, and C. Haslett. 1993. Interleukin-8 and development of adult respiratory distress syndrome in.at-risk patient groups. Lancet 341: 643-647.
36. Baughman, R. P., K. L. Gunther, M. C. Rashkin, D. A. Keeton, and E. N. Pattishall. 1996. Changes in the inflammatory response of the lung during acute respiratory distress syndrome: prognostic indicators. Am. J. Respir. Crit. Care Med. 154: 76-81.
37. Steinberg, K. P., J. A. Milberg, T. R. Martin, R. J. Maunder, B. A. Cockrill, and L. D. Hudson. 1994. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 150: 113-122.
38. Schwartz, M. D., E. E. Moore, F. A. Moore, R. Shenkar, P. Moine, J. B. Haenel, and E. Abraham. 1996. Nuclear factor-κB is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit. Care Med. 24: 1285-1292.
39. Sadikot, R. T., H. Zeng, M. Joo, M. B. Everhart, T. P. Sherrill, B. Li, D.-S. Cheng, F. E. Yull, J. W. Christman, and T. S. Blackwell. 2006. Targeted immunomodulation of the NF-κB pathway in airway epithelium impacts host defense against Pseudomonas aeruginosa. J. Immunol. In press.